Skip to main content

U.S. Nasal Spray Market - Latest Updates with Market Exhaustive Survey And Demand Overview

 


US Nasal Spray Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 610 million cases and 6.51 million deaths due to coronavirus (COVID-19) were reported till September 22, 2022, across the globe.

Impact of COVID-19 on Demand and Supply of Nasal Spray

The COVID-19 pandemic and lockdown in various countries across the globe has impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products.

However, the COVID-19 pandemic has increased research and development for the use of nasal spray for the treatment and prevention of coronavirus infection. This is assisting in the market growth, which is expected to boost the U.S. nasal spray market growth over the forecast period. For instance, in 2021, scientists at the University of Pennsylvania and Regeneron, a biotechnology company, announced that they were collaborating and investigating whether technology developed for Adeno-Associated Virus (AAV) gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.

US Nasal Spray Market is estimated to be valued at US$ 9,272.8 Mn in 2022, and is expected to exhibit a CAGR of 6.8% over the forecast period (2022-2030).

Advantages of using nasal sprays are expected to boost the U.S. nasal spray market growth over the forecast period.

There are various benefits of using nasal route of administration and nasal sprays for drug delivery, this is expected to fuel the U.S. nasal spray market growth over the forecast period. Benefits of using saline nasal sprays include –

·         Saline nasal sprays aid in clearing the nose of allergies, viruses, and other irritants

·         It helps to hydrate and clean nasal tissues, which is crucial for maintaining nasal immunity

·         When nasal saline is administered initially, the effectiveness of medicinal nasal sprays may be increased

·         The spray also thins extra mucus in the sinuses and nose, which can relieve discomfort and congestion

 

Comments

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...

Custom Antibody Service Market Segmentation Application, Technology and Market Analysis to 2028

  The immune system produces antibodies in response to pathogen invasion. Antigens are the collective term for the invasive bacteria, viruses, or other foreign molecules. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. It is possible to have antibodies made using custom antibody production when an antibody is required against a particular antigen but it is not offered by a supplier. These antibodies can be either polyclonal or monoclonal, depending on how they are produced and harvested. Polyclonal  antibodies  are capable of recognizing multiple sites on an antigen. They are derived from different B-cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line. Global custom antibody service market is estimated to be valued at  US$ 444.85 Million in 2022  and expected to reach  US$ 930.46 million by 2030 , witnessing a  CAGR of 9.7 %  over...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.